ASHLEY RICHEY: Open Payments
NPI 1609539923 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 73 payments from 14 companies in 2025. Trend: 2023 $1,956 · 2024 $1,521 · 2025 $1,105
Food & beverage: $1,030Education: $75
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $254 |
| ABBVIE INC. | 12 | $170 |
| Novartis Pharmaceuticals Corporation | 14 | $159 |
| UCB, Inc. | 9 | $138 |
| Janssen Biotech, Inc. | 2 | $89 |
| Lilly USA, LLC | 3 | $67 |
| PFIZER INC. | 3 | $50 |
| KYOWA KIRIN, INC. | 2 | $43 |
| Genentech USA, Inc. | 2 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
Products named: Bimzelx, KRYSTEXXA, TREMFYA, RINVOQ, COSENTYX, ENBREL, SKYRIZI, TALTZ.
Industry payments across IN — which companies pay providers there.
